Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gmo Product PlatformTSE:3695 -0.14%71 PE Ratio (TTM) is 17.86 as of Jul. 17, 2026, which is 3% below its 10-year median of 18.49. GuruFocus rates TSE:3695 with a GF Score™ of 71/100 and a GF Value™ of 円1,484.07 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,645 Software companies, Gmo Product Platform ranks better than 57.02% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-17), Gmo Product Platform's share price is
円1448.00.
Gmo Product Platform's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円81.08. Therefore, Gmo Product Platform's PE Ratio (TTM) for today is 17.86.
The historical rank and industry rank for Gmo Product Platform's PE Ratio (TTM) or its related term are showing as below:
TSE:3695'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 10.64 Med: 18.49 Max: 67.2
Current: 17.86
During the past 13 years, the highest PE Ratio (TTM) of Gmo Product Platform was 67.20. The lowest was 10.64. And the median was 18.49.
TSE:3695's PE Ratio (TTM) is ranked better than 57.02% of 1645
companies
in the Software industry
Industry Median: 20.97
vs TSE:3695: 17.86
During the past 12 months, Gmo Product Platform's average EPS without NRIGrowth Rate was -54.50% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -37.90% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -12.90% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 4.90% per year.
During the past 13 years, Gmo Product Platform's highest 3-Year average EPS without NRI Growth Rate was 38.90% per year. The lowest was -37.90% per year. And the median was 10.95% per year.
Gmo Product Platform's EPS (Basic) for the
three
months ended in Dec. 2025 was 円0.00.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was 円81.08.
Gmo Product Platform (TSE:3695) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Gmo Product Platform PE Ratio (TTM) Related Terms
Gmo Product Platform PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Gmo Product Platform's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3695 vs MSFT, ORCL, PLTR: PE Ratio (TTM) Comparison
For the Software - Infrastructure subindustry, Gmo Product Platform's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gmo Product Platform PE Ratio (TTM) vs Software Industry
For the Software industry and Technology sector, Gmo Product Platform's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Gmo Product Platform's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Gmo Product Platform's Share Price of today is 円1448.00.
Gmo Product Platform's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円81.08.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Gmo Product Platform (TSE:3695) has a PE Ratio (TTM) of 17.86 as of Jul. 17, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Gmo Product Platform and its competitors. This is near median its historical median of 18.49. Over the past decade, Gmo Product Platform's PE Ratio (TTM) has ranged from 10.64 to 67.20. According to the industry distribution chart, Gmo Product Platform ranks #707 out of 1645 companies in the Software industry, placing it in the top 43%.
Is Gmo Product Platform's PE Ratio (TTM) too high?
Gmo Product Platform's current PE Ratio (TTM) of 17.86 is near median its 10-year median of 18.49. Over the past 10 years, this metric has ranged from a low of 10.64 to a high of 67.20. The Software industry median PE Ratio (TTM) is 20.97. Gmo Product Platform's value of 17.86 is 14.8% below this industry median. Based on the distribution chart, Gmo Product Platform ranks #707 out of 1645 companies in the Software industry, which is above the industry midpoint. Overall, Gmo Product Platform has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gmo Product Platform's PE Ratio (TTM) compare to MSFT and ORCL?
According to the Software industry distribution chart, Gmo Product Platform ranks #707 out of 1645 companies for PE Ratio (TTM). This puts Gmo Product Platform in the upper half of its industry. The industry median PE Ratio (TTM) is 20.97. Gmo Product Platform's value of 17.86 is 14.8% below this benchmark. Historically, Gmo Product Platform's own PE Ratio (TTM) has ranged from 10.64 to 67.20 over the past decade. While the company's 10-year median is 18.49 vs. the industry median of 20.97, Gmo Product Platform has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Software company?
The median PE Ratio (TTM) among Software companies is 20.97, based on 1,645 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gmo Product Platform's current PE Ratio (TTM) of 17.86 is 14.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Gmo Product Platform and its competitors. For the Software industry, the median PE Ratio (TTM) is 20.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gmo Product Platform's current PE Ratio (TTM) is 17.86, which is near median its own 10-year median of 18.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gmo Product Platform stock overvalued right now?
Based on GuruFocus' analysis, Gmo Product Platform (TSE:3695) is currently considered Fairly Valued. The stock's GF Value™ is 円1,484.07, compared to a current price of 円1,448.00 — trading 2.4% below its estimated fair value. The current PE Ratio (TTM) is 17.86, which is near median its 10-year median of 18.49 and 14.8% below the Software industry median of 20.97. Gmo Product Platform's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Gmo Product Platform (TSE:3695), the current PE Ratio (TTM) is 17.86 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gmo Product Platform (TSE:3695) Overvalued in 2026?
Based on GuruFocus' analysis, Gmo Product Platform stock appears to be undervalued.
The current stock price of 円1,448.00 is trading 2.4% below its estimated GF Value™ of 円1,484.07.
GuruFocus considers Gmo Product Platform to be Fairly Valued.
Key valuation signals for TSE:3695:
PE Ratio (TTM): 17.86 (near median its 10-year median of 18.49)
GF Value™: 円1,484.07 vs. price of 円1,448.00 (2.4% below fair value)
Industry Position: 14.8% below the Software median (#707 of 1645)
No single metric tells the full story. See the TSE:3695 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gmo Product Platform Inc offers online payment and business-to-business payment platform services that help startups, tech companies, and SMEs improve payment processing and operational efficiency. The solutions of the company support various business models with digital payment infrastructure and finance-related services.
71GF Score
Get the complete analysis for TSE:3695
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3695 has been successfully added to your 
